Do you want to read an article? Please log in or register.
Effects of Sacubitril/Valsartan Across the Spectrum of Renal Impairment in Patients With Heart Failure
Heart Failure
Related content
Heart Failure
Effect of sacubitril/valsartan in heart failure with preserved ejection fraction across the age spectrum in PARAGON-HF
Eur J Heart Fail
Wang X, Vardeny O, Claggett B, Vaduganathan M, Hegde SM, Skali H, Pabon MA, Foà A, Chatur S, Kosztin A, O'Meara E, Rouleau J, Redfield M, Lam CSP, Zile M, Packer M, Shah AM, Cikes M, Gori M, Merkely B, Pfeffer MA, McMurray JJV, Solomon SD
doi: 10.1002/ejhf.3535
Heart Failure
Cause-specific death in heart failure across the ejection fraction spectrum: A comprehensive assessment of over 100 000 patients in the Swedish Heart Failure Registry
Eur J Heart Fail
Settergren C, Benson L, Shahim A, Dahlström U, Thorvaldsen T, Savarese G, Lund LH, Shahim B
doi: 10.1002/ejhf.3230
Heart Failure
In-Hospital or Out-of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE-HF Trial
J Am Heart Assoc
Nouhravesh N, Cyr D, Hernandez AF, Morrow DA, Velazquez EJ, Ward J, Sarwat S, Sharma K, Williamson K, Starling RC, Lepage S, Zieroth S, Solomon SD, Mentz RJ
doi: 10.1161/JAHA.124.037899
Heart Failure
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial
Eur J Heart Fail
Tromp J, Kosiborod MN, Angermann CE, Collins SP, Teerlink JR, Ponikowski P, Biegus J, Ferreira JP, Nassif ME, Psotka MA, Brueckmann M, Blatchford JP, Steubl D, Voors AA
doi: 10.1002/ejhf.3218
Heart Failure
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial
Eur J Heart Fail
Vaduganathan M, Cannon CP, Jardine MJ, Heerspink HJL, Arnott C, Neuen BL, Sarraju A, Gogate J, Seufert J, Neal B, Perkovic V, Mahaffey KW, Kosiborod MN
doi: 10.1002/ejhf.3292
Heart Failure
Implementation of guideline-recommended therapies in heart failure with reduced ejection fraction according to heart failure duration: An analysis of 55 581 patients from the Swedish Heart Failure (SwedeHF) Registry
Eur J Heart Fail
Shahim A, Linde C, Savarese G, Dahlström U, Lund LH, Hage C
doi: 10.1002/ejhf.3565
RECOMMENDED
Heart Failure
Association of sex with in-hospital management and outcomes of patients with heart failure: data from the REAL-HF registry: The impact of sex in patients hospitalized for heart failure
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Am Heart J
Sanna GD, Erre GL, Cameli M, Guerra F, Pastore MC, Marini A, Campora A, Gironella P, Costamagna M, Mandoli GE, Casiraghi M, Scuteri A, Lisi M, Casu G, Deidda M, Dessalvi CC, REAL-HF investigators
doi: 10.1016/j.ahj.2024.08.018
Heart Failure
Effects of Tirzepatide on the Clinical Trajectory of Patients with Heart Failure, a Preserved Ejection Fraction, and Obesity
Circulation
Zile MR, Borlaug BA, Kramer CM, Baum SJ, Litwin SE, Menon V, Ou Y, Weerakkody GJ, Hurt KC, Kanu C, Murakami M, Packer M, SUMMIT Trial Study Group
doi: 10.1161/CIRCULATIONAHA.124.072679
Heart Failure
Inpatient versus outpatient diagnosis of heart failure across the spectrum of ejection fraction: a population cohort study
Heart
Wang H, Gao C, Guignard-Duff M, Cole C, Hall C, Baruah R, Das S, Gao H, Mamza JB, Lang CC, Mordi IR
doi: 10.1136/heartjnl-2024-324160